Caprock Group, Inc. Mannkind Corp Transaction History

Caprock Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$3.14 - $6.14 $175,840 - $343,840	-56,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$1.79 - $4.04 $28,640 - $64,640	16,000 Added 40.0%	56,000 $175,000
Q4 2018 Jan 29, 2019	BUY	$1.02 - $2.05 $40,800 - $82,000	40,000 New	40,000 $42,000
Q1 2018 Apr 23, 2018	SELL	$2.28 - $3.8 $45,599 - $76,000	-20,000 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$2.28 - $6.71 $45,599 - $134,200	20,000	20,000 $48,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.